A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments
- Substances:Nolasiban
Spain- Participants:18–64 years
- Substances:Nolasiban
- Sponsor:ReproNovo ApS
Rare diseases
Investigational molecules
Locations
Back to Spain445 clinical trials in Galdakao, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainStudy to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency
SpainStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
SpainStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
SpainA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
SpainA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
SpainA study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer
SpainA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
SpainA study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis
SpainA safety study of romosozumab in children and adolescents with osteogenesis imperfecta
SpainA study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia
SpainEvaluation of Lymphocyte-Sparing Radiotherapy and All-Trans Retinoic Acid in Lateralized Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Carcinoma
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on breast cancer treatments, including trials for HER2-positive and triple-negative variants. Research encompasses innovative therapies for pancreatic adenocarcinoma and colon cancer.
Multiple trials evaluating novel drug combinations and targeted therapies for improved patient outcomes.
Comprehensive research into pulmonary fibrosis and respiratory conditions, with studies examining new treatments for COPD and pulmonary embolism management.
Innovative approaches to improve lung function and patient quality of life.
Investigations into cardiomyopathy prevention and treatment, including trials for acute coronary syndromes and peripheral arterial disease management.
Focus on preventive strategies and improved treatment protocols for heart conditions.
Studies addressing endocrine disorders, including hypothyroidism and its effects. Research on hepatic conditions and smoking cessation therapies.
Diverse therapeutic approaches targeting various medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.